Marshall Wace, LLP Essa Pharma Inc. Transaction History

Marshall Wace, LLP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$1.75 - $3.44 $164,025 - $322,427	93,729 Added 438.13%	115,122 $209,000
Q2 2022 Aug 15, 2022	BUY	$3.15 - $7.94 $67,387 - $169,860	21,393 New	21,393 $67,000
Q1 2022 May 16, 2022	SELL	$6.18 - $14.44 $59,451 - $138,912	-9,620 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$7.8 - $14.38 $37,900 - $69,872	-4,859 Reduced 33.56%	9,620 $137,000
Q2 2021 Aug 13, 2021	BUY	$24.17 - $34.28 $349,957 - $496,340	14,479 New	14,479 $414,000

35.1M

15.8K

21K

Ticker EPIX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 44,073,100
Market Cap $75.4M
Description
ESSA Pharma Inc., a clinical stage pharmaceutical company, focuses on developing novel and proprietary therapies for the treatment of prostate cancer. It develops EPI-7386, an oral candidate that is in a Phase I clinical study for the treatment of patients with metastatic castration-resistant prostate cancer. The company has collaboration agreem...

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

Stay updated on Marshall Wace, LLP with notifications on news.